Additionally, several clinical trials have demonstrated that the expression of Tim-3 is associated with severe dysfunction of T cells in different types of cancers such as non-small-cell lung carcinoma (NSCLC), renal cell carcinoma (RCC), colon cancer and gastric cancer 58, 59. Here, HAVCR2 is linked to non-small cell lung carcinoma.